A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia

NCT04455581 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Hypercholesterolemia

Interventions

DRUG: SHR-1209

Sponsor

Jiangsu HengRui Medicine Co., Ltd.